title: Unusual adverse event with vandetanib in metastatic medullary thyroid cancer.
authors.affiliation: Medical Oncology Department, Centre Leon Berard, 28 rue Laennec, 69008 Lyon, France.
authors.forename: Sophie
authors.initials: S
authors.lastname: Duplomb
authors.forename: Amandine
authors.initials: A
authors.lastname: Benoit
authors.forename: Laura
authors.initials: L
authors.lastname: Mechtouff-Cimarelli
authors.forename: Tae-Hee
authors.initials: TH
authors.lastname: Cho
authors.forename: Olfa
authors.initials: O
authors.lastname: Derbel
authors.forename: Jean Louis
authors.initials: JL
authors.lastname: Peix
authors.forename: Christelle
authors.initials: C
authors.lastname: de la Fouchardière
mesh_terms: D018278:Carcinoma, Neuroendocrine; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010880:Piperidines / Q000008:administration & dosage / Q000009:adverse effects*; D011799:Quinazolines / Q000008:administration & dosage / Q000009:adverse effects*; D013964:Thyroid Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D010880:Piperidines; D011799:Quinazolines; C452423:vandetanib